EU and UK Physician Payment Sunshine Coming - May Eclipse US Version

In June 2012, the “code on disclosure of transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations” was announced by the European Federation of Pharmaceutical Industries and Associations (EFPIA). Starting 1 July 2016, the Association of the British Pharmaceutical Industry (ABPI) will publish details of British pharmaceutical company payments made to healthcare professionals, including nurses and pharmacists.


This goes beyond the US Physician Payment Sunshine Act, which doesn’t require companies to publicly report payments to nurse practitioners or physician assistants, even though they are allowed to write prescriptions in most states (see here). This, however, may change if legislation proposed by Sen. Charles Grassley, R-Iowa, and Sen. Richard Blumenthal, D-Conn., becomes law. The legislation would expand the disclosure requirement beginning in 2017 to include physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives (read more about that here).

What do UK health professionals think of ABPI's plans to publish these data?

Read more »